The adverse metabolic effects of antipsychotic treatment should be considered when psychiatrists are formulating a patient’s treatment regime. Pre-existing cardiovascular risk factors should prompt use of atypical antipsychotics, which may have a lower risk of adverse metabolic side effects (see table 2).